LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. As industry leading innovators, we have developed a next-generation point of care Platform, that is transforming community-based healthcare. Our technology provides fast, high performance and accessible diagnostic solutions at the point of need.
.jpg.ashx?height=75&width=200&bgcolor=white)
Test benefits The LumiraDx SARS-CoV-2 Ab Test is designed to be used in commu...
Test benefits The measurement of CRP provides information for the detection a...
Test benefits Microfluidic immunofluorescence assay Results in 5 minu...
Test benefits Microfluidic immunofluorescence assay Optimize patient ...
Test benefits Microfluidic immunofluorescence assay Optimize patient ...